Groowe / Newsroom / RDY

⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

RDY News

Dr. Reddy's Laboratories Limited American Depositary Shares

Aurigene Oncology Limited Announces Encouraging Initial Data From 1 st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies

businesswire.com Dec 2, 2025 2:05 PM